🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “China” Clear

  1. recombinant human thrombopoietin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thrombocytopenia

    approved small molecule completed

    1 trial

  2. sIPV+DTaP+HepA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab active

    1 trial

  3. silk suture

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    approved other completed

    1 trial

  4. sodium valproate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epilepsy

    approved small molecule active

    1 trial

  5. tacrolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Moderate/Severe Atopic Dermatitis

    approved small molecule completed

    1 trial

  6. telbivudine (ROADMAP)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule active

    1 trial

  7. tong-jiang granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome

    approved small molecule active

    1 trial

  8. treatment with CAZ-AVI

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Patients With Critically Ill Infections

    approved small molecule active

    1 trial

  9. ulinastatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatitis

    approved small molecule on hold

    1 trial

  10. vaccinated with Sabin IPV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Polio

    approved mab completed

    1 trial

  11. 0.01% concentration atropine drops

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acupressure

    small molecule active

    1 trial

  12. 0.1% bromfenac ophthalmic solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cataract

    small molecule completed

    1 trial

  13. 1.23% fluoride foam application

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Dental Caries in Children

    small molecule completed

    1 trial

  14. 100mg aspirin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Recurrent Acute Pancreatitis

    small molecule active

    1 trial

  15. 100mg diclofenac

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Post-ERCP Acute Pancreatitis

    small molecule terminated

    1 trial

  16. 18F-PSMA-1007

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    small molecule active

    1 trial

  17. 2L PEG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bowel Preparation Scale

    small molecule completed

    1 trial

  18. 75 mg acetylsalicylic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Preeclampsia

    small molecule active

    1 trial

  19. 99mTc-4BOH SPECT myocardial perfusion imaging

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    other active

    1 trial

  20. A+ HA(tm)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    other completed

    2 trials

  21. AIM-CHD Mobile Health Intervention

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Secondary Prevention of Coronary Heart Disease

    other completed

    1 trial

  22. Akkermansia Probiotics

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colo-rectal Cancer

    other active

    1 trial

  23. Albumin paclitaxel/neutrophil drug

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    mab active

    1 trial

  24. Albumin-Bound Paclitaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Carcinoma

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources